# Ep190: Neil Kumar on Building a Rare Disease Drug Company

Page: https://stenobird.com/podcast/the-long-run-with-luke-timmerman-1124799/ep190-neil-kumar-on-building-a-rare-disease-drug-company
Text version: https://stenobird.com/podcast/the-long-run-with-luke-timmerman-1124799/ep190-neil-kumar-on-building-a-rare-disease-drug-company.md
Podcast: [The Long Run with Luke Timmerman](https://stenobird.com/podcast/the-long-run-with-luke-timmerman-1124799)
Published: 2025-11-20T13:48:19+00:00
Episode link: https://soundcloud.com/longrunpodcast/ep190-neil-kumar-on-building-a-rare-disease-drug-company
Audio file: https://feeds.soundcloud.com/stream/2215845644-longrunpodcast-ep190-neil-kumar-on-building-a-rare-disease-drug-company.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-long-run-with-luke-timmerman-1124799/episodes/ep190-neil-kumar-on-building-a-rare-disease-drug-company
Duration seconds: 4392

## Resource

Neil Kumar is founder and CEO of Palo Alto, Calif.-based BridgeBio Pharma, a rare disease drug developer.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-long-run-with-luke-timmerman-1124799/episodes/ep190-neil-kumar-on-building-a-rare-disease-drug-company/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-long-run-with-luke-timmerman-1124799/ep190-neil-kumar-on-building-a-rare-disease-drug-company.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.